论文部分内容阅读
要改革创新,就要有勇于担当、敢啃硬骨头的勇气3月27日,上海医药发布年报。2014年,上海医药实现营业收入人民币923.99亿元,同比增长18.12%;实现归属于上市公司股东净利润同比增长17.06%。两位数的增长状态在今年得到持续,2015年第一季度,上海医药实现营业收入人民币251.25亿元,同比增长18.10%。这家企业的努力惊人。过去的一年,宏观经济增速下滑、医保控费、药
To reform and innovation, we must have the courage to bear the courage to bite the bones March 27, Shanghai Pharmaceutical released the annual report. In 2014, Shanghai Pharmaceutical achieved operating revenue of RMB92,399 million, representing an increase of 18.12% over the same period of last year; net profit attributable to shareholders of listed companies increased by 17.06% over the same period of last year. Double-digit growth continued this year. In the first quarter of 2015, Shanghai Pharmaceutical recorded revenue of RMB25,225 million, representing an increase of 18.10% over the same period of last year. The work of this business is amazing. In the past year, the macroeconomic growth rate fell, medical insurance control fees and medicine